Eye Clinic, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, United Kingdom.
Indian J Ophthalmol. 2021 Sep;69(9):2437-2440. doi: 10.4103/ijo.IJO_3796_20.
Alcohol delamination of the corneal epithelium (ADCE) is a therapeutic option for patients with recurrent corneal erosion (RCE) who do not respond to nonsurgical management of lubricants and extended wear contact lens. The aim of the study is to report on three-year efficacy and safety of ADCE for RCE of traumatic etiology.
This is a retrospective review of consecutive patients who underwent ADCE for traumatic RCE in a local hospital between January 2010 and January 2020. The outcomes at a 3-year follow-up review are included. Nonsurgical therapy used; intra- and postoperative complications were recorded. ADCE was only offered to those who remained symptomatic despite maximum topical lubrications and/or extended wear contact lens. Success was defined as the absence of recurrence of corneal erosion.
Twenty-six eyes of 26 patients with RCE caused by trauma underwent ADCE. The mean age of patients was 39 years. The follow-up period was a minimum of 36 months. Three eyes (11.5%) had recurrence of corneal erosion after ADCE at the 3-year follow-up. Recurrence was noted at months 2, 23, and 36 postoperatively in these patients. All patients reported significant improvement in symptoms associated with recurrent erosion. Ten eyes (38.5%) stopped all topical lubricants postoperatively. No intra- or postoperative complications were noted in our study.
This study documents the long-term safety and efficacy of alcohol delamination of corneal epithelium at 3 years for patients with RCE of traumatic origin.
酒精性角膜上皮分层术(ADCE)是一种治疗复发性角膜糜烂(RCE)的方法,适用于对润滑剂和延长佩戴接触镜的非手术治疗无反应的患者。本研究旨在报告 ADCE 治疗外伤性 RCE 的三年疗效和安全性。
这是对 2010 年 1 月至 2020 年 1 月期间在当地医院接受 ADCE 治疗外伤性 RCE 的连续患者进行的回顾性研究。包括 3 年随访评估的结果。记录非手术治疗方法、术中及术后并发症。仅对那些尽管接受了最大剂量的局部滴眼和/或延长佩戴接触镜仍有症状的患者提供 ADCE。成功定义为角膜糜烂无复发。
26 例因创伤导致 RCE 的患者的 26 只眼接受了 ADCE。患者的平均年龄为 39 岁。随访时间至少为 36 个月。3 只眼(11.5%)在 ADCE 后 3 年随访时出现角膜糜烂复发。这些患者在术后第 2、23 和 36 个月出现复发。所有患者均报告与复发性糜烂相关的症状明显改善。10 只眼(38.5%)术后停止使用所有局部滴眼剂。本研究未观察到术中或术后并发症。
本研究证明了酒精性角膜上皮分层术治疗外伤性 RCE 的长期安全性和有效性,随访时间为 3 年。